ATE343001T1 - Das parkin-protein als ubiquitinligase - Google Patents

Das parkin-protein als ubiquitinligase

Info

Publication number
ATE343001T1
ATE343001T1 AT01906293T AT01906293T ATE343001T1 AT E343001 T1 ATE343001 T1 AT E343001T1 AT 01906293 T AT01906293 T AT 01906293T AT 01906293 T AT01906293 T AT 01906293T AT E343001 T1 ATE343001 T1 AT E343001T1
Authority
AT
Austria
Prior art keywords
ubiquitin ligase
parkin protein
parkin
protein
image
Prior art date
Application number
AT01906293T
Other languages
English (en)
Inventor
Yoshikuni Mizuno
Nobuyoshi Shimizu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE343001T1 publication Critical patent/ATE343001T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Noodles (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
AT01906293T 2000-02-24 2001-02-26 Das parkin-protein als ubiquitinligase ATE343001T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000047801 2000-02-24

Publications (1)

Publication Number Publication Date
ATE343001T1 true ATE343001T1 (de) 2006-11-15

Family

ID=18569991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01906293T ATE343001T1 (de) 2000-02-24 2001-02-26 Das parkin-protein als ubiquitinligase

Country Status (10)

Country Link
US (1) US20050042607A1 (de)
EP (1) EP1262557B1 (de)
AT (1) ATE343001T1 (de)
AU (1) AU2001234171A1 (de)
CA (1) CA2398703A1 (de)
DE (1) DE60123934T2 (de)
DK (1) DK1262557T3 (de)
ES (1) ES2272444T3 (de)
MX (1) MXPA02008256A (de)
WO (1) WO2001062957A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017348B1 (en) * 2005-12-12 2011-09-13 Elan Pharma International Limited Assay for Parkinson's Disease therapeutics
ATE520025T1 (de) * 2005-12-12 2011-08-15 Elan Pharm Inc Test für morbus-parkinson-therapeutika

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1063294B1 (de) * 1998-02-09 2006-01-11 Boehringer Ingelheim International GmbH Dns oder gene, die an der parkinsonschen krankheit beteiligt sind
GB9826276D0 (en) * 1998-12-01 1999-01-20 Univ Leeds Therapeutic agents for use in degenerative disorders
US7070940B2 (en) * 2002-07-18 2006-07-04 Aventis Pharma S.A. Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein

Also Published As

Publication number Publication date
DE60123934D1 (de) 2006-11-30
EP1262557A1 (de) 2002-12-04
US20050042607A1 (en) 2005-02-24
WO2001062957A1 (fr) 2001-08-30
ES2272444T3 (es) 2007-05-01
EP1262557B1 (de) 2006-10-18
MXPA02008256A (es) 2003-01-28
DE60123934T2 (de) 2007-10-18
CA2398703A1 (en) 2001-08-30
EP1262557A4 (de) 2003-05-02
AU2001234171A1 (en) 2001-09-03
DK1262557T3 (da) 2006-11-13

Similar Documents

Publication Publication Date Title
ITPD990279A0 (it) Treppiede perfezionato, in particolare per impieghi ottici e fotografi ci.
DE60238493D1 (de) Is von seltenen zellen verwendete markierte zellen
BR0115124B1 (pt) dispositivo para fundir uma amostra hiperpolarizada sàlida, mÉtodo para produzir uma amostra hiperpolarizada fundida, e, uso de um dispositivo ou mÉtodo.
DE60207160D1 (de) Entwickungseinheit, Prozesskartusche und Bildaufzeichungsmethode
NL1007031A1 (nl) Hydroxyfenyltriazinen.
DE60233539D1 (de) Optisches Informationsaufzeichnungsmedium, Informationsaufzeichnungsverfahren, und dieses Aufzeichnungsmedium benutzendes Gerät
DE60216538D1 (de) Toner, Entwickler und Bildaufzeichnungsverfahren
DE60113921D1 (de) Tragbares Kraftwerkzeug
DE69931201D1 (de) Photoresist copolymer.
DK1214088T3 (da) Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner
DE60123934D1 (de) Das parkin-protein als ubiquitinligase
DE60208598D1 (de) Toner, Bildherstellungsverfahren und Prozesskassette
ATE332807T1 (de) Infrarotempfindliche photoempfindliche zusammensetzung
BR0106896B1 (pt) aparelho de projeção centrìfuga.
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
WO2002057744A3 (en) Automated microfabrication-based biodetector
GB2387077B (en) Foldable type portable information terminal,answer holding method used in the same,and program therefor
ES1036257Y (es) Foco perfeccionado.
NL1024693A1 (nl) Lichtontvangend apparaat, lichtdetectie apparaat, en een optisch signaal reproducerend apparaat.
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
FR2702234B1 (fr) Dispositif sanitaire destiné, particulièrement en ville, aux animaux domestiques.
藤原義弘 Influence of bacterial endosymbionts on host distributions in deep-sea chemosynthetic ecosystems
Sakamoto Toward an Accessible City for Every Person (Part 2)—The Pedestrian Bridges and the Parks—
ES1046632Y (es) Foco perfeccionado.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1262557

Country of ref document: EP

REN Ceased due to non-payment of the annual fee